MAP2K7 and hepatocellular carcinoma: These alterations were considered putative oncogenic drivers of HCC in the DEN-induced model, as they may lead to the constitutive activation of Ras/Raf/MEK/ERK and Wnt/β-catenin signaling pathways, deregulating cell proliferation, growth, and survival processes.